Assenagon Asset Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-24,040
| Closed | -$1.97M | – | 1362 |
|
|
2022
Q4 | $1.97M | Hold |
24,040
| – | – | 0.01% | 788 |
|
|
2022
Q3 | $2.27M | Sell |
24,040
-211
| -0.9% | -$19.9K | 0.01% | 645 |
|
|
2022
Q2 | $4.72M | Sell |
24,251
-4,936
| -17% | -$961K | 0.02% | 538 |
|
|
2022
Q1 | $6.78M | Sell |
29,187
-48,766
| -63% | -$11.3M | 0.02% | 434 |
|
|
2021
Q4 | $30.7M | Buy |
77,953
+17,564
| +29% | +$6.92M | 0.09% | 136 |
|
|
2021
Q3 | $27M | Buy |
60,389
+512
| +0.9% | +$229K | 0.09% | 149 |
|
|
2021
Q2 | $23.3M | Buy |
+59,877
| New | +$23.3M | 0.08% | 178 |
|
|
2020
Q3 | – | Sell |
-30,948
| Closed | -$11.3M | – | 1077 |
|
|
2020
Q2 | $11.3M | Buy |
+30,948
| New | +$11.3M | 0.07% | 152 |
|
|
2020
Q1 | – | Sell |
-16,849
| Closed | -$6.94M | – | 749 |
|
|
2019
Q4 | $6.94M | Buy |
+16,849
| New | +$6.94M | 0.04% | 173 |
|
|
2018
Q4 | – | Sell |
-16,621
| Closed | -$17.2M | – | 951 |
|
|
2018
Q3 | $17.2M | Buy |
16,621
+7,114
| +75% | +$7.35M | 0.17% | 86 |
|
|
2018
Q2 | $8.73M | Buy |
9,507
+4,018
| +73% | +$3.69M | 0.1% | 155 |
|
|
2018
Q1 | $5.35M | Buy |
+5,489
| New | +$5.35M | 0.07% | 175 |
|